vimarsana.com

Latest Breaking News On - Kim golodetz - Page 4 : vimarsana.com

Sensus Healthcare, Inc (SRTS) Q3 2022 Earnings Call Transcript

Sensus Healthcare, Inc. (NASDAQ:NASDAQ:SRTS) Q3 2022 Earnings Conference Call November 3, 2022 16:30 ET Company Participants Kim Golodetz - Investor Relations Joe Sardano - Chairman and.

United statesNew yorkSan franciscoYi chenAlex nowakAnthony vendettiJavier rampollaScott henryBenjamin haynorJoe sardanoMichael sardanoGlynis ablonMark nestorKim golodetzCompany participantsSensus healthcare inc

Sensus Healthcare, Inc (SRTS) CEO Joe Sardano on Q2 2022 Results - Earnings Call Transcript

Sensus Healthcare, Inc. (NASDAQ:NASDAQ:SRTS) Q2 2022 Earnings Conference Call August 4, 2022 16:30 ET Company Participants Kim Golodetz - Senior Vice President and Principal,.

United statesNew yorkFort lauderdaleRepublic ofYi chenAlex nowakAnthony vendettiJavier rampollaScott henryJoe sardanoMichael sardanoGlynis ablonMark nestorKim golodetzLippert heilshorn associates incCompany participants

Myomo, Inc (MYO) CEO Paul Gudonis on Q1 2022 Results - Earnings Call Transcript

Myomo, Inc. (NYSE:NYSE:MYO) Q1 2022 Results Earnings Conference Call May 11, 2022, 04:30 PM ET Company Participants Kim Golodetz - IR, LHA Investor Relations Paul Gudonis - Chief Executive.

New yorkUnited statesPaul gudonisJim sidotiDave henryBen haynorPaul nouriCarolyn curranScott henryKim golodetzExchange commissionCompany participantsSidoti companyAlliance global partnersMyomo incorporated first quarterMyomo inc

Sensus Healthcare, Inc (SRTS) CEO Joe Sardano on Q1 2022 Results - Earnings Call Transcript

Sensus Healthcare, Inc. (NASDAQ:NASDAQ:SRTS) Q1 2022 Earnings Conference Call May 5, 2022 04:30 PM ET Company Participants Kim Golodetz - Senior Vice President and Principal,.

United statesSan diegoAlex nowakLos angelesAnthony vendettiJavier rampollaJoe sardanoMichael sardanoGlynis ablonMark nestorKim golodetzLippert heilshorn associates incCompany participantsSensus healthcare incAmerican society for laser medicineResearch center

Oragenics : Extends Collaboration with the National Research Council of Canada to Develop Vaccine against the Omicron Variant - Form 8-K

Oragenics, Inc. today announced it has extended a licensing and collaboration agreement with the National Research Council of Canada that will enable Oragenics to pursue an intranasal vaccine. | December 20, 2021

United statesMichael sullivanKim golodetzExchange commissionOragenics incNational research council of canadaNational research council of canada toOragenics extends collaborationNational research councilResponse challengeOragenic executiveSecurities litigation reform actChief financial officerNc stock exchangePress releaseNtranasal ogen us6840233026

vimarsana © 2020. All Rights Reserved.